9 months ago
Elekta Introduces AI-Powered Evo CT-Linac in India
Elekta, a company that makes machines for treating cancer, has brought a new machine called Evo to India.
Evo is special because it uses AI to help doctors see tumors more clearly and adjust the treatment as needed.
This is important because many patients in India have complex cancer cases.
Evo was shown for the first time in India at two big conferences in Kolkata and Guwahati.
The machine is designed to help doctors give better and more personalized treatment to more patients.
Elekta says Evo will help make high-quality cancer treatment available to more people in India and around the world.
Elekta introduced its AI-powered Evo CT-Linac in India, showcased at AROICON in Kolkata and AMPICON in Guwahati.
Evo features high-definition, AI-enhanced imaging and adaptive radiotherapy capabilities for personalized cancer treatment.
The CT-Linac allows clinicians to adjust therapy based on daily anatomical changes, crucial for complex and advanced-stage diseases common in India.
Evo's adaptive capabilities and streamlined workflow aim to improve efficiency and treatment quality in high-volume centers.
Elekta emphasizes its commitment to making high-quality cancer treatment accessible globally, with Evo marking a significant milestone in the Indian market.
- Who
- Elekta, a leader in precision radiation therapy
- What
- Introduction of Evo, an AI-powered CT-Linac for cancer treatment
- Where
- Guwahati, India, at the AMPICON conference
- When
- December 5, 2025
- Why
- To provide high-quality, personalized cancer treatment in India
Key facts
- Company
- Elekta
- Product
- Evo CT-Linac
- Key Features
- AI-enhanced imaging, adaptive radiotherapy
- Conferences
- AROICON (Kolkata), AMPICON (Guwahati)
- Date
- December 5, 2025
- Location
- Guwahati, India
- CDSCO Registration
- Yes (with limited global availability)
Quotes
Feras Al Hasan
Head of TIMEA, Elekta
“We are delighted to bring our flagship innovation Evo Elekta to India. Evo brings a new level of flexibility to India’s radiotherapy landscape and is designed to help centres deliver more personalized, efficient care. Its ability to support both online and offline adaptive treatments on a CT-Linac gives clinicians the confidence to adjust therapy based on daily anatomical changes which is especially important in India, where many patients present with complex and advanced stage diseases. Our aim is to strengthen Elekta’s commitment to making high-quality cancer treatment accessible to more patients across the globe.”
thehindubusinessline.com
Shankar Seshadri
VP & Head - India Sub-continent, Elekta
“India needs radiotherapy solutions that combine precision with practicality and Evo is uniquely positioned to address India’s growing cancer burden and evolving patient needs. Its adaptive capabilities and streamlined workflow help high-volume centres treat more patients without compromising treatment quality. The arrival of Evo in India marks a significant milestone, as it will help accelerate our market growth in the region.”
thehindubusinessline.com
